Tourmaline Bio
Financial ratios & Valuation

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-37.00-4.78-1.83M-10.52-2.95N/A-1.83M
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
16.970.73-7.35K-10.510.60N/A-7.35K
Price/Cash Flow ratio
-38.04-5.65-41.58-32.12-4.42N/A-41.58
Price/Free Cash Flow ratio
-36.87-5.29-39.19-17.99-4.41N/A-39.19
Price/Earnings Growth ratio
N/A-0.0018.39K-0.00-0.00N/A18.39K
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/AN/A5222345.13%N/AN/AN/A5222345.13%
Return on Assets
-43.28%-14.86%-0.60%-216.54%-20.03%N/A-0.60%
Return On Equity
-45.85%-15.34%0.4%99.84%-20.54%N/A0.4%
Return on Capital Employed
-46.34%-15.18%0.4%-254.69%-22.11%N/A0.4%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/A
Quick Ratio
17.8044.280.396.0941.75N/A0.39
Cash ratio
17.015.160.396.0528.13N/A0.39
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A626.29113.6524.39K11.84KN/A113.65
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A1N/A0.00N/A1
Debt Equity Ratio
N/AN/A-0.66N/A0.00N/A-0.66
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/A-1.97N/A0.00N/A-1.97
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/A-266.58N/A-127.06N/A-266.58
Company Equity Multiplier
1.051.03-0.66-0.461.02N/A-0.66
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.061.061.781.00N/A1.06
Cash Flow Coverage Ratio
N/AN/A-266.58N/A-127.06N/A-266.58
Short Term Coverage Ratio
N/AN/A-266.58N/A-127.06N/A-266.58
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A